I
have been using the new FreeStyle Tracker with my PDA for the past 2
weeks and will have a follow-up in next weeks issue.
Due
to the amount of information from ADA and ENDO 2002 we will have 20
news items in the newsletter for a few weeks to catch up with all that
is
happening in Diabetes.
Eric S.
Freedland, MD, brings us part
10 Manipulating
Macronutrient Ratios,
learn how the ratios have changed over the years and how the changes
have overlooked obvious shortfalls.
We
had some exclusive interviews at the ADA and ENDO conferences and will
have those for you starting next week.
Make
sure you read this weeks’ feature from Sheri Shafer RD, CDE;
Antioxidants- What we know, What we
need to know
The
Pritchett and Hull Patient Handout Program is full
thanks to all participants, however there are a few more spots
available for the SnoreQuell
Study.
Watch
for information for the upcoming AADE convention in Philadelphia.
We will have a booth with some exciting information.
Make sure you put it in your calendar to stop by our booth #919
and check it out.
Check
out http://www.fwcade.org
This is the affiliate website we provided for the Tampa Bay
Chapter of AADE. For information on how you can get one for your
organization just click
here to send us an email
Have
a safe,
happy
and healthy Fourth
of July holiday
Consider
making Diabetes in Control Your home page.
Dave Joffe, Editor-in-Chief ; Steve Freed, Publisher
Advertorial
The
Hyperactive Platelet in Type 2 Diabetes
Credits:
2.00 hours AMA PRA category 1
Fee:
None
Sponsor:
Baylor College of Medicine, Houston, Texas
Notes:
This
program covers the impact of diabetes on the risk of atherothrombosis,
recent advances in antiplatelet therapy, and different strategies for
acute coronary syndrome specific to the diabetic patient. This FREE
on-line enduring material
CME activity, sponsored by Baylor College of Medicine, Houston,
Texas, offers 2 hours of AMA PRA
category 1 credit for those who successfully complete the posttest,
evaluation, and registration forms.
This CME Circle activity is
hosted on
Medscape and
was developed from the proceedings of a satellite symposium
held in conjunction with the American Diabetes Association 61st
Scientific Session held June 25, 2001, in Philadelphia, Pennsylvania.
To
access this free on-line activity, click here
Product
Update:
A1cNow
is Less Than 9 Dollars!
Metrika
receives NGSP
Certification for their A1cNow instant A1c test.
Now
less than 9 dollars for the first and only A1c test that is instant and
disposable.
For more info on how you can now use it in your office practice
and quantiy discounts
Click
Here!
1.
ADA: Prevent Diabetes by Walking Just 30 Minutes a Day
Click
Here
2.
ADA: Good Glycemic Control Is Not Enough in Managing Diabetes
Click
Here
3.
ADA: Noninvasive Blood Glucose Monitor Tested in Diabetics*
Click
Here
4.
ADA: Insulin Patch May Help Dodge the Needle
Click
Here
5.
66% of Heart Attack Patients have Undiagnosed Diabetes or PreDiabetes*
Click
Here
6.
Ghrelin, A Hunger Hormone’ Linked to Long-Term Body Weight Regulation
Click
Here
7.
Stem Cell Research Considered A Source of New Therapies to Treat
Diabetes
Click
Here
8.
GLP-1 Analog Has An “Anti-Diabetic” Effect When Glucose Levels are
Elevated
Click
Here
9.
Efficacy of an Oral Insulin Spray (Oralin) Delivered Through The Buccal
Mucosa
Click
Here
10.
Effects of a Ketogenic, or High-Fat, Diet as a Treatment for Obesity
Click
Here
11.
Growth Hormone and Metformin Reduces Fat Mass and CVD Factors
Click
Here
12.
Postmenopausal Women Taking Folic Acid Reduce Risk of Heart Disease
Click
Here
13.
ADA: Artificial Pancreas Safe and Effective*
Click
Here
14.
ACC, AHA, NHLBI Clinical Advisory Confirms Safety, Effectiveness of
Statins
Click
Here
15.
"Globesity" 22 Million Children Worldwide are Overweight or
Obese
Click
Here
16.
Increased Concentration of Nitric Oxide in Type 2 Diabetes with Insulin
Resistance
Click
Here
17.
Importance of Family History of Diabetes in Patients with Type 2
Diabetes
Click
Here
18.
Cozaar (Losartan) Lowered Risk Of Total Mortality In Patients With
Diabetes By 39% Versus Atenolol
Click
Here
19.
INGAP Peptide - An Initiator of Beta Cell Growth*
Click
Here
20.
INGAP Peptide Induces Islet Cell Neogenesis from Human Duct-like Islet
Progenitor Cells
Click
Here
News
Flash - News Flash
Diabetes
Breakthrough- Scientists Get Stem Cells to Release Insulin
Diabetes
sufferers may someday be able to throw away their needles
PORTLAND
- Diabetes sufferers may someday be able to throw away their needles
thanks to a recent breakthrough at Oregon Health Sciences University.
Researchers
there have developed embryonic stem cells from monkeys that produce and
release insulin. The hope is that this discovery will lead to a method
of transplanting the stem cells into an insulin patient, ending the
"Diabetes lifestyle" as patients now know it.
Further
research will be necessary - the researchers want to perform the entire
process on a diabetic monkey before trying to develop a procedure for
human patients. If successful, this breakthrough could mean the
successful end of an entire century of efforts to develop
insulin-producing cells to replace non-functioning ones in a diabetic's
body. OHSU
can be reached at (503) 494-8231.
Open
Studies for your participation
(Educators
have said that just by participating in a study, they can get better
outcomes)
1.
Closed!
The
Pritchett & Hull Patient Handout Medical Professional Experience
Survey—receive
high quality patient handouts at no charge, and give the company your
feedback. Click
Here
2.
SnoreQuell
Patient Experience Survey: will
evaluate the effectiveness of this product in decreasing or eliminating
snoring. This will be determined by comparing before and after
questionnaires to be completed by each participant. This survey is open
to educators, diabetes patients and their partners.
Click
Here
3.
Gym Study II: Gymnemosupium
II A
combination of the extracts of Gymnema sylvestre, Pterocarpus marsupium,
Diachrome and Vanadium
4. RELAXATION – WarmFeet® study Version
II
Open
For Registration (less labor intensive version)
Soon
to Open Studies...
1.
A new feedback study for you and your patients- Using a
medical/nutritional assessment survey
2.
The S.T.E.P. study, 10,000
Steps To Enhanced Prevention
Quote
of the Week
ADA: Noninvasive Blood Glucose Monitor Tested in Diabetics*
WASHINGTON
(The
FDA)
-
FDA
today
cleared
a
new
laboratory
test
to
measure
skin
cholesterol
in
adults
with
clinically
significant
disease
AND
anyone
suspected
to
have
coronary
artery
disease.
The
test
can
help
determine
the
amount
of
cholesterol
in
skin
using
the
palm
of
the
hand.
Other
cholesterol
tests
currently
used
by
laboratories
measure
cholesterol
from
blood
samples.
